ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
US Tech 100
18,066.00
-0.07%
Dow Jones
40,003.59
0.34%
Brent Oil
83.76
0.00%
Bitcoin
66,786.76
-0.44%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Phathom Pharmaceuticals Inc (PHAT)

  7. Phathom Pharmaceuticals Inc (PHAT) News

PHAT

Phathom Pharmaceuticals (PHAT)

Phathom Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PHAT
DateTimeSourceHeadlineSymbolCompany
05/15/20248:00AMGlobeNewswire Inc.Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2024 Annual MeetingNASDAQ:PHATPhathom Pharmaceuticals Inc
05/09/20244:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PHATPhathom Pharmaceuticals Inc
05/09/20248:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PHATPhathom Pharmaceuticals Inc
05/09/20248:00AMGlobeNewswire Inc.Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:PHATPhathom Pharmaceuticals Inc
04/29/20248:00AMGlobeNewswire Inc.Phathom Pharmaceuticals to Report First Quarter 2024 Financial Results and Provide Business Update on Thursday, May 9, 2024NASDAQ:PHATPhathom Pharmaceuticals Inc
04/03/20248:00AMGlobeNewswire Inc.Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:PHATPhathom Pharmaceuticals Inc
03/26/20248:00AMGlobeNewswire Inc.Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”NASDAQ:PHATPhathom Pharmaceuticals Inc
03/07/20244:01PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PHATPhathom Pharmaceuticals Inc
03/07/20248:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PHATPhathom Pharmaceuticals Inc
03/07/20248:00AMGlobeNewswire Inc.Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:PHATPhathom Pharmaceuticals Inc
02/29/20248:00AMGlobeNewswire Inc.Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 7, 2024NASDAQ:PHATPhathom Pharmaceuticals Inc
02/13/20248:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PHATPhathom Pharmaceuticals Inc
02/13/20248:00AMGlobeNewswire Inc.Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Tablets for Erosive GERD and Associated Heartburn Added to Express Scripts National Formularies for Commercial PatientsNASDAQ:PHATPhathom Pharmaceuticals Inc
01/31/20248:00AMGlobeNewswire Inc.Phathom Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:PHATPhathom Pharmaceuticals Inc
01/22/20248:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PHATPhathom Pharmaceuticals Inc
12/15/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PHATPhathom Pharmaceuticals Inc
12/14/20238:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PHATPhathom Pharmaceuticals Inc
12/14/20238:00AMGlobeNewswire Inc.Phathom Pharmaceuticals Announces Expansion of Existing Loan and Security Agreement with Hercules CapitalNASDAQ:PHATPhathom Pharmaceuticals Inc
12/06/20238:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PHATPhathom Pharmaceuticals Inc
12/06/20238:00AMGlobeNewswire Inc.Phathom Pharmaceuticals Announces FDA Acceptance for Filing of VOQUEZNA® (vonoprazan) Tablets New Drug Application for the Treatment of Heartburn Associated with Non-Erosive GERDNASDAQ:PHATPhathom Pharmaceuticals Inc
11/28/20238:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PHATPhathom Pharmaceuticals Inc
11/28/20238:00AMGlobeNewswire Inc.Phathom Pharmaceuticals Announces Commercial Availability of VOQUEZNA® (vonoprazan) Tablets, a Powerful First-In-Class PCAB for the Treatment of Erosive GERD and Relief of Associated HeartburnNASDAQ:PHATPhathom Pharmaceuticals Inc
11/20/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PHATPhathom Pharmaceuticals Inc
11/09/20234:02PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PHATPhathom Pharmaceuticals Inc
11/09/20238:05AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PHATPhathom Pharmaceuticals Inc
11/09/20238:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PHATPhathom Pharmaceuticals Inc
11/09/20238:00AMGlobeNewswire Inc.Phathom Pharmaceuticals Reports Third Quarter 2023 Results and Recent Business UpdatesNASDAQ:PHATPhathom Pharmaceuticals Inc
11/08/20237:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PHATPhathom Pharmaceuticals Inc
11/03/20234:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PHATPhathom Pharmaceuticals Inc
11/01/20235:50PMDow Jones NewsPhathom Pharmaceuticals Gets FDA Approval for Voquezna TreatmentNASDAQ:PHATPhathom Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PHAT

Your Recent History

USOTC
FSRN
Fisker (PK)
NASDAQ
CRKN
Crown Electrokinetics
NASDAQ
FFIE
Faraday Future Intellige...
USOTC
CLNV
Clean Vision (QB)
USOTC
CATV
4Cable TV (PK)
NASDAQ
GWAV
Greenwave Technology Sol...
USOTC
MGON
Megola (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
FDCT
FDCTech (PK)
NASDAQ
JAGX
Jaguar Health
USOTC
KGKG
Kona Gold Beverage (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
SFLM
SFLMaven (PK)
USOTC
CYDY
CytoDyn (QB)
USOTC
PHIL
PHI (PK)
USOTC
CBIA
Canopus Biopharma (PK)
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved